PUBLISHER: Grand View Research | PRODUCT CODE: 1679357
PUBLISHER: Grand View Research | PRODUCT CODE: 1679357
The global healthcare cold chain third party logistics market size is expected to reach USD 66.12 billion by 2030, growing at a CAGR of 7.64% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by increasing reliance on biopharmaceuticals and other temperature-sensitive products. Biopharmaceuticals require stringent temperature controls to maintain efficacy, making cold chain logistics indispensable. Moreover, the growing prevalence of chronic diseases, along with the demand for precision medicine and gene therapies, has boosted the need for reliable temperature-controlled transportation. In addition, regulatory requirements for the storage and handling of biologics further emphasize the role of specialized logistics providers in ensuring compliance and product safety.
In addition, pharmaceutical and biopharmaceutical companies are increasingly focusing on expanding into emerging markets to strengthen their market position. Emerging countries are witnessing increasing demand for high-value drugs, necessitating robust cold storage and transportation networks. This expansion is driving investments in infrastructure, including temperature-controlled warehouses and specialized transportation fleets. In addition, strategic partnerships between pharmaceutical firms and 3PL providers are becoming more common to ensure seamless global distribution.
Key market players are adopting various strategies to strengthen their position in the healthcare cold chain logistics market. These include expanding global networks, investing in cutting-edge cold storage facilities, and leveraging digital solutions for enhanced tracking and compliance. Strategic mergers, acquisitions, and partnerships are also shaping the competitive landscape, allowing companies to extend their market reach and service capabilities. In February 2024, FedExmentioned its new FedEx Life Science Center in India, which will support the clinical trial logistics & storage requirements of healthcare customers in the Indian market & those shipping to India from around the world.